Cutenox 60 mg / 0.6 ml
Cutenox 60 mg / 0.6 ml Cutenox contains Enoxaparin Sodium, a low molecular weight heparin produced by alkaline depolymerization of heparin benzyl ester. It acts primarily by binding to antithrombin III, accelerating the inhibition of coagulation Factor Xa and Factor IIa (thrombin), with a higher potency ratio against Factor Xa. This prevents clot formation and propagation. It is indicated for the treatment of established deep vein thrombosis (DVT) with or without pulmonary embolism (PE), as well as the management of acute coronary syndromes, including unstable angina and myocardial infarction (NSTEMI and STEMI).
| Brand | Cutenox |
| Storage Temperature | Store below 25°C (Do not freeze, Protect from light) |
| Prescription Needed | Yes |
| Composition | Enoxaparin Sodium |
| Strength | 60 mg / 0.6 ml |
| Form | Solution for Injection |
| Pack Size | 10 Pre-filled Syringes |
| Packaging | Pre-filled syringes |
| Country of Origin | Made In India |
| Manufacturer | Gland Pharma Limited |
Cutenox 60 mg / 0.6 ml
Cutenox 60 mg / 0.6 ml Cutenox contains Enoxaparin Sodium, a low molecular weight heparin produced by alkaline depolymerization of heparin benzyl ester. It acts primarily by binding to antithrombin III, accelerating the inhibition of coagulation Factor Xa and Factor IIa (thrombin), with a higher potency ratio against Factor Xa. This prevents clot formation and propagation. It is indicated for the treatment of established deep vein thrombosis (DVT) with or without pulmonary embolism (PE), as well as the management of acute coronary syndromes, including unstable angina and myocardial infarction (NSTEMI and STEMI).
